BioViva USA Inc™
  • HOME
  • About Us
  • Contact us
  • Invest
  • OUR TEAM
  • faqs
BioViva USA Inc™
  • HOME/
  • About Us/
  • Contact us/
  • Invest/
  • OUR TEAM/
  • faqs/
blog-banner-min.png
BioViva USA Inc™

The Cure is in the Helix of Humanity

Blog

Press releases, updates and original articles

BioViva USA Inc™
  • HOME/
  • About Us/
  • Contact us/
  • Invest/
  • OUR TEAM/
  • faqs/
March 08, 2018

Overexpression of genes to suppress dsRNA innate immunity

March 08, 2018/ Liz Parrish
600px-Humanstemcell.jpg

BioViva scientist Ali Fallah et al have worked on the reprogramming potential of GCS (germline derived stem cells) the self-renewal capacity of which makes them a good source for research and clinical use, and shown that their innate immunity can be manipulated via overexpression of three key genes.

 

Source: NCBI Pub Med

March 08, 2018/ Liz Parrish/ Comment

Liz Parrish

  • BioViva’s aims to be an advanced ...
  • What’s All The Buzz? BioViva’s ...

We are gene therapy innovation leaders. We develop platforms
to treat severe genetic disorders and cellular aging.

Join Our Newsletter

Thank you!

Contact us

  • Seattle WA

Navigation

  • Why BioViva
  • FAQ
  • Become a partner
  • Investors
  • Gene therapy
  • The science of aging

Follow us

  • facebook
  • twitter
  • instagram
  • linkedin
  • youtube

©2022. BioViva All rights reserved | For any inquires, contact info@bioviva-science.com